SCHEMBL26416161

SCHEMBL26416161

c1ccc(-c2ccc(-c3cc(-c4nc(-c5ccccc5)cc(-c5ccccc5)n4)cc4c3oc3cc5ccccc5cc34)cc2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 7/20 0.40
KMT2A Q03164 7/20 0.40
ALDH1A1 P00352 6/20 0.40
HPGD P15428 6/20 0.40
MAPT P10636 5/20 0.40
NTSR1 P30989 1/20 0.40
CYP2C19 P33261 2/20 0.39
TP53 P04637 1/20 0.39
CYP1A2 P05177 1/20 0.39
HIF1A Q16665 1/20 0.39
HSD17B10 Q99714 1/20 0.39
CYP1A1 P04798 1/20 0.38
CYP1B1 Q16678 1/20 0.38
ACACA Q13085 1/20 0.36
KDM4E B2RXH2 3/20 0.36
LMNA P02545 2/20 0.36
GLA P06280 1/20 0.36
MAOA P21397 2/20 0.36
MAOB P27338 2/20 0.36
ADORA2A P29274 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25666491 0.96 MEN1 (0.42) MEN1KMT2AALDH1A1HPGDMAPT
SCHEMBL24066229 0.96 MEN1 (0.42) MEN1KMT2AALDH1A1HPGDMAPT
SCHEMBL25708412 0.92 MAPT (0.36) MEN1KMT2AALDH1A1HPGDMAPT
SCHEMBL24066103 0.92 MAPT (0.36) MEN1KMT2AALDH1A1HPGDMAPT
SCHEMBL25666485 0.92 ENPP1 (0.41) MEN1KMT2AALDH1A1HPGDMAPT
SCHEMBL24255561 0.91 KMT2A (0.35) MEN1KMT2AALDH1A1HPGDMAPT
SCHEMBL24586344 0.90 CYP1A1 (0.40) MEN1KMT2AALDH1A1HPGDMAPT
SCHEMBL26420659 0.90 KMT2A (0.35) MEN1KMT2AALDH1A1HPGDMAPT
SCHEMBL24586567 0.90 MAPT (0.36) MEN1KMT2AALDH1A1HPGDMAPT
SCHEMBL24585647 0.90 MAPT (0.36) MEN1KMT2AALDH1A1HPGDMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230128360-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME, COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT EMITTING DEVICE LT MATERIALS CO., LTD. (KR) 2023-04-27 US disclosed
US-20230128360-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME, COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT EMITTING DEVICE LT MATERIALS CO., LTD. (KR) 2023-04-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230128360-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME, COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT EMITTING DEVICE CRY1, ORC3, ODC1 MEN1 334/4885KMT2A 1453/4885ALDH1A1 27/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.